FDA Drug Recalls

Recalls / Class III

Class IIID-0843-2020

Product

Frovatriptan Succinate Tablets, 2.5mg, packaged in 1 blister card of 9 tablets per carton, Rx Only, Manufactured by: Almac Pharma Services Limited, Craigavon, BT63 5UA, UK; Manufactured for: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC 0603-3718-34.

Affected lot / code info
Lot Number: 9698818; labeled expiration AUG 2022; actual expiration APR 2022

Why it was recalled

Labeling: Incorrect or Missing Lot and/or Exp Date: Product incorrectly labeled with an expiration date of August 2022 rather than the correct expiration date of April 2022.

Recalling firm

Firm
Par Pharmaceutical Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
1 Ram Ridge Rd, Chestnut Ridge, New York 10977-6714

Distribution

Quantity
9,936 cartons
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2020-02-10
FDA classified
2020-02-13
Posted by FDA
2020-02-19
Terminated
2020-11-17
Status
Terminated

Source: openFDA Drug Enforcement endpoint. Recall record D-0843-2020. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class III recall: drug · FDA Drug Recalls